Bright focuses on the Evaluable Patient and seeing that patient through to the conclusion of his study participation. Early terminations for reasons other than safety or severe adverse events are sometimes preventable. This is especially true for trials that require long hospital stays. Being attuned to the patient experience and keeping patients occupied and comfortable is essential to reducing the percentage of early terminations for non-safety issues. Bright Pharmaceutical Services supports sites in retaining patients by creating protocol specific programs that cater to patient needs. For each indication and study there are a compendium of resources to draw on. Let Bright fashion a Patient Retention Program that focuses on patient education, and catering to their well-being and comfort during a trial.
Bright focuses on the therapeutic area, patient population and requirements of your study. Taking these extra steps allows sites to optimize the chances of retaining patients in lengthy or challenging projects.